Franz König

4.8k total citations
133 papers, 3.0k citations indexed

About

Franz König is a scholar working on Statistics and Probability, Surgery and Economics and Econometrics. According to data from OpenAlex, Franz König has authored 133 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Statistics and Probability, 24 papers in Surgery and 18 papers in Economics and Econometrics. Recurrent topics in Franz König's work include Statistical Methods in Clinical Trials (44 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers) and Optimal Experimental Design Methods (15 papers). Franz König is often cited by papers focused on Statistical Methods in Clinical Trials (44 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers) and Optimal Experimental Design Methods (15 papers). Franz König collaborates with scholars based in Austria, Germany and United States. Franz König's co-authors include Andreas Schedle, Trevor Lucas, Péter Bauer, Wolfgang R. Sperr, Frank Bretz, Martin Posch, Alexander Franz, Heinz Schmidli, Amy Racine and Willi Maurer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Franz König

117 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franz König Austria 30 756 529 447 380 377 133 3.0k
R.-D Hilgers Germany 39 239 0.3× 286 0.5× 596 1.3× 104 0.3× 61 0.2× 190 5.4k
Antonia Zapf Germany 33 74 0.1× 299 0.6× 519 1.2× 57 0.1× 17 0.0× 172 3.5k
Martina Mittlböck Austria 36 180 0.2× 58 0.1× 1.9k 4.2× 85 0.2× 34 0.1× 164 4.7k
Johannes Krisam Germany 23 57 0.1× 205 0.4× 220 0.5× 63 0.2× 21 0.1× 117 2.1k
Frank Krummenauer Germany 41 44 0.1× 76 0.1× 1.4k 3.1× 95 0.3× 27 0.1× 197 5.5k
Bernd Röhrig Germany 24 79 0.1× 23 0.0× 209 0.5× 104 0.3× 19 0.1× 54 2.0k
Edith Motschall Germany 32 26 0.0× 128 0.2× 431 1.0× 76 0.2× 22 0.1× 68 3.0k
Alessio Signori Italy 35 28 0.0× 371 0.7× 514 1.1× 80 0.2× 7 0.0× 235 4.7k
Maja Pohar Perme Slovenia 26 456 0.6× 20 0.0× 590 1.3× 286 0.8× 28 0.1× 86 2.7k
Sandrine Katsahian France 38 79 0.1× 28 0.1× 1.4k 3.2× 119 0.3× 13 0.0× 131 6.0k

Countries citing papers authored by Franz König

Since Specialization
Citations

This map shows the geographic impact of Franz König's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz König with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz König more than expected).

Fields of papers citing papers by Franz König

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz König. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz König. The network helps show where Franz König may publish in the future.

Co-authorship network of co-authors of Franz König

This figure shows the co-authorship network connecting the top 25 collaborators of Franz König. A scholar is included among the top collaborators of Franz König based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz König. Franz König is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
König, Franz, Tim Friede, Andrew C. Hooker, et al.. (2025). A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards. Statistics in Medicine. 44(5). e70019–e70019.
3.
König, Franz, et al.. (2025). Closed MCP‐Mod for Pairwise Comparisons of Several Doses With a Control. Statistics in Medicine. 44(10-12). e70124–e70124.
4.
Gold, Stefan M., Kim Donoghue, Franz König, et al.. (2025). Transforming the evidence landscape in mental health with platform trials. Nature Mental Health. 3(3). 276–285. 5 indexed citations
5.
Krenn, Katharina, Matthias Urban, Roman Ullrich, et al.. (2025). Efficacy of solnatide to treat pulmonary permeability edema in SARS-CoV-2 positive patients with moderate to severe ARDS: A randomized controlled pilot-trial. Anaesthesia Critical Care & Pain Medicine. 44(3). 101520–101520.
6.
Hees, Katharina, Franz König, Dominic Magirr, et al.. (2025). Treatment-Control Comparisons in Platform Trials Including Non-Concurrent Controls. Statistics in Biopharmaceutical Research. 18(1). 79–96. 1 indexed citations
7.
Gidh‐Jain, Madhavi, et al.. (2024). Developing generic templates to shape the future for conducting integrated research platform trials. Trials. 25(1). 204–204. 5 indexed citations
8.
Burnett, Thomas, Franz König, & Thomas Jaki. (2024). Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress. Statistics in Medicine. 43(18). 3447–3462. 4 indexed citations
9.
Bethe, Ullrich, Zoi Dorothea Pana, Christian Drosten, et al.. (2024). Innovative approaches for vaccine trials as a key component of pandemic preparedness – a white paper. Infection. 52(6). 2135–2144. 1 indexed citations
10.
Hees, Katharina, Franz König, Martin Posch, et al.. (2024). Regulatory Issues of Platform Trials: Learnings from EU‐PEARL. Clinical Pharmacology & Therapeutics. 116(1). 52–63. 7 indexed citations
11.
König, Franz, Günter U. Höglinger, Franziska Hopfner, et al.. (2024). Efficiency of multivariate tests in trials in progressive supranuclear palsy. Scientific Reports. 14(1). 25581–25581. 1 indexed citations
12.
Robertson, David S., James Wason, Franz König, Martin Posch, & Thomas Jaki. (2023). Online error rate control for platform trials. Statistics in Medicine. 42(14). 2475–2495. 9 indexed citations
14.
Ballarini, Nicolás, et al.. (2021). Optimizing subgroup selection in two‐stage adaptive enrichment and umbrella designs. Statistics in Medicine. 40(12). 2939–2956. 12 indexed citations
15.
Eichhorn, Tanja, Ingrid Linsberger, Lucia Lauková, et al.. (2021). Analysis of Inflammatory Mediator Profiles in Sepsis Patients Reveals That Extracellular Histones Are Strongly Elevated in Nonsurvivors. Mediators of Inflammation. 2021(1). 8395048–8395048. 9 indexed citations
16.
Meyer, Elias Laurin, Peter Mesenbrink, Cornelia Dunger‐Baldauf, et al.. (2020). The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review. Clinical Therapeutics. 42(7). 1330–1360. 82 indexed citations
17.
Ballarini, Nicolás, Yi‐Da Chiu, Franz König, Martin Posch, & Thomas Jaki. (2020). A critical review of graphics for subgroup analyses in clinical trials. Pharmaceutical Statistics. 19(5). 541–560. 14 indexed citations
18.
König, Franz, et al.. (1988). Lexikon der Religionen. Herder eBooks. 3 indexed citations
19.
König, Franz, et al.. (1986). Die bleibende Bedeutung des Zweiten Vatikanischen Konzils.
20.
König, Franz. (1964). Zarathustras Jenseitsvorstellungen und das Alte Testament. Herder eBooks. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026